By Regulatory Approvals — Recon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challenges RAPS
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 20, 2026.